Showing results (511-520 of 526) with videos related to
Sort By:
Pageof 53
Cancer Research|February 12, 2022
A Short Isoform of Spermatogenic Enzyme GAPDHS Functions as a Metabolic Switch and Limits Metastasis in MelanomaJennifer G Gill, Samantha N Leef, Vijayashree Ramesh, et al.Biorxiv : the Preprint Server for Biology|September 21, 2023
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisSpencer D Shelton, Sara House, Vijayashree Ramesh, et al.JPGN Reports|May 19, 2023
Hemosuccus Pancreaticus Following Acute Pancreatitis in a 12-years-old Boy Secondary to Pancreatic Pseudoaneurysm Treated With Endovascular Coil EmbolizationChristiana Ekezie, Kara G Gill, Patrick R Pfau, et al.Diabetes|January 1, 2016
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD MiceRonald G Gill, Philippe P Pagni, Tinalyn Kupfer, et al.Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|June 27, 2014
Measurement of spatial and temporal variation in volatile hazardous air pollutants in Tacoma, Washington, using a mobile membrane introduction mass spectrometry (MIMS) systemNicholas G Davey, Cole T E Fitzpatrick, Jacob M Etzkorn, et al.Current Oncology (Toronto, Ont.)|December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with ALK-rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessmentB C Tse, B I Said, Z J Fan, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 29, 2020
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting ReportAnat R Tambur, Patricia Campbell, Anita S Chong, et al.Science Advances|August 7, 2024
The origins of mammal growth patterns during the Jurassic mammalian radiationElis Newham, Ian J Corfe, Philippa Brewer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trialN Zdenkowski, J F Forbes, F M Boyle, et al.British Journal of Cancer|December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupK Aabo, M Adams, P Adnitt, et al.Pageof 53